Cerebrus clinches Swiss biotech deal and agrees to takeover by Vanguard
Saturday 04 December 1999
Cerebrus, part owned by biotechnology entrepreneur Chris Evans, is to license its serotonin receptor programme, which assists the treatment of obesity, to Hoffman-La Roche. The Swiss company is to fund development and commercialisation of the treatment, while Cerebrus will receive milestone payments. Hoffman-La Roche is already a world leader in obesity treatments.
Cerebrus will receive a share of royalties of any resulting product, but revenues are not anticipated until the latter half of the next decade. Vanguard Medica is buying Cerebrus for shares worth pounds 9.6m, less than half a previous offer it is thought to have made.Dr George Poste, the chairman, will leave Cerebrus.
The deal will ease the pressure on Vanguard, which suffered a setback last month when the US Food and Drug Administration demanded that it repeat early-stage trials for frovatriptan, a migraine drug.
The deal paves the way for further acquisitions of private research outfits by the quoted biotechs, which are already in the throes of consolidation. Prolifix, an Oxfordshire-based cancer research company, was tipped as a possible target yesterday; Eli Lilly, the US pharmaceuticals group, took a stake in the company in October.
- 2 Mystery man who gave mum heart-warming note on train 'wanted to put a smile on her face'
- 5 Amal Clooney gives excellent answer to fashion question at European Court of Human Rights
King Salman: Just five days in, Saudi Arabia's new king has already overseen a beheading
Mystery man who gave mum heart-warming note on train 'wanted to put a smile on her face'
Michelle Obama highlights harsh restrictions faced by Saudi women after meeting King Salman without wearing a headscarf
Amal Clooney gives excellent answer to fashion question at European Court of Human Rights
Mafia's wall of silence broken: Victim of Cosa Nostra's extortion rackets in its Corleone heartland co-operates with authorities for the first time ever
'We would evict Queen from Buckingham Palace and allocate her council house,' say Greens
Greece elections: Syriza and EU on collision course after election win for left-wing party
British Muslim school children suffering a backlash of abuse following Paris attacks
British grandmother Lindsay Sandiford faces execution by firing squad in Indonesia
Liberal Democrat minister defends comments suggesting immigration causes pub closures
Louise Mensch says 'F**K YOU' in explosive tweets about David Cameron, Saudi Embassy and the Queen over King Abdullah tributes
iJobs Money & Business
£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...
£25000 - £35000 per annum: Recruitment Genius: A Technical Report Writer is re...
Competitive salary & benefits!: MBDA UK Ltd: MBDA UK LTD Indirect Procurement...
£16500 - £16640 per annum: Recruitment Genius: This fast growing Finance compa...